#KidneyWk on X 17 hours ago

RT @Eledon_Pharma: In this @Neph_Times video, nephrology expert John Gill, M.D., analyzes results presented at #KidneyWk from the Phase 2 B…

View Post

#KidneyWk on X 22 hours ago

Pediatric results from DUPLEX show sparsentan is well tolerated and achieves superior, sustained proteinuria reduction versus the maximum IRB dose ...

View Post

#KidneyWk on X 1 day ago

RT @Neph_Times: WATCH Matthew Weir, MD, discussing results from the phase 2 Explore-CKD trial of lorundrostat presented at #KidneyWk. #neph…

View Post

#KidneyWk on X 1 day ago

RT @AsnEpc: #KidneyWk events on Nov. 9 from 9:30–11:30 AM CST - Dialysis-Dependent AKI: Therapies for Kidney Recovery: https://t.co/d9rr6AU…

View Post

#KidneyWk on X 2 days ago

RT @AsnEpc: #KidneyWk events on Nov. 9 from 9:30–11:30 AM CST - Dialysis-Dependent AKI: Therapies for Kidney Recovery: https://t.co/d9rr6AU…

View Post

#KidneyWk on X 2 days ago

RT @NephroP: Professor @vandyniyyar sharing must-know kidney/bladder #POCUS pearls for nephrologists at the #KidneyWk precourse. https://t.…

View Post

#KidneyWk on X 2 days ago

RT @NephroP: Prof @vandyniyyar providing a nice overview of vascular access imaging #Kidneywk https://t.co/842HQERcL2

View Post

#KidneyWk on X 2 days ago

RT @ASNKidney: What do you want to see at #KidneyWk 2026? Now’s the time to shape it. Submit your session and faculty suggestions for next…

View Post

#KidneyWk on X 2 days ago

RT @Neph_Times: WATCH Matthew Weir, MD, discussing results from the phase 2 Explore-CKD trial of lorundrostat presented at #KidneyWk. #neph…

View Post

#KidneyWk on X 3 days ago

RT @Neph_Times: What role do CD38+ immune cells play in AMR and glomerular disease? Georg Böhmig, MD, shares insights from #KidneyWk and wh…

View Post